drug manufacturing
-
MedCity Influencers, BioPharma
Fine-Tuning, Prompt Engineering are Keys to Delivering Real Generative AI Solutions to Commercial Pharma Operations Today
Generative AI further enhances the value of prompt engineering by synthesizing important insights from various interactions, including text, images, compliant transcripts, and call notes. By automating this process, generative AI quickly transforms on-the-ground insights into robust analytics.
-
As Cell Therapy Gains Ground, Efforts Emerge to Improve CAR T-Manufacturing
Cell therapy offers a treatment option for some advanced blood cancers, but the manufacturing process is lengthy and complex. The biopharmaceutical industry is working on various technologies that could make manufacturing faster and more efficient, or perhaps supplant the current process altogether.
-
Payer’s Place: Dawn Maroney
Dawn Maroney, President, Markets of Alignment Health and CEO of Alignment Health Plan, to discuss how they are using technology to provide better service and care to consumers.
-
MedCity Influencers, BioPharma
Why and How To Achieve Effective Data Management Strategies Early in the Biopharma Lifecycle
Cloud-based data management solutions help the industry meet its business and compliance challenges. These platforms need to replace traditional data management methods and workflows for biopharma companies and contract development and manufacturing organizations that seek competitive advantages.
-
How the agile in pharma trend is transforming drug development
Emergn Principal Consultant Mario Moreira shared insights on how pharma companies can use the principles of Value, Flow and Quality to shorten drug development timelines and deliver better patient outcomes through improved ways of working.
-
Resilience turns to Harvard for biologics manufacturing tech, inks 5-year R&D pact
Biomanufacturing technologies company Resilience is partnering with Harvard in a deal that could see innovations from the university’s labs commercialized under new businesses. Resilience has committed $30 million in funding to support Harvard biomanufacturing research.
-
Devices & Diagnostics, Pharma, BioPharma
Life sciences use of digital twins mirrors its application in other industries
Life sciences companies are using “digital twins” for everything from drug discovery to manufacturing. A panel of experts at MedCity News’ INVEST Digital Health conference discussed how this capability to run virtual simulations is changing practices now while also shaping the industry for the years to come.
-
FDA keeps brand-name drugs on A fast path to market — despite manufacturing concerns
Generics made overseas sometimes suffer from poor quality control but even some of the newest, most expensive brand-name medicines have been plagued by quality and safety concerns during production, according to analysis.
-
MIT invents machine for fast pharma prototype-making
“If there was an emergency you could have these little plants located all over. You just turn them on and you start turning out different pharmaceuticals that are needed.”
-
Applying Remote Patient Monitoring to Surgery Prep and Recovery, Oncology and Women’s Health
Join us to learn about the latest trends in remote monitoring and how to extend its benefits beyond chronic conditions to more patients – all while using fewer staff resources.
Promoted
Payer’s Place: Dr. Anil Singh
Dr. Anil Singh shares his insights into the strategies employed by the organization to identify the most effective digital solutions for their members.
Promoted
Discover the Next-Gen Platform for Integrated Collaborative Care
Beyond EHRs and digital front doors, reducing the gaps in patient care journeys.
